Tag: Bristol-Myers Squibb
Finding capital for biotech companies remains difficult
biotech research German biotech companies currently have many drugs in clinical trials. (Photo: IMAGO / Shotshop) Frankfurt Since the boom during the corona pandemic, German biotech companies have been raising…
Billion dollar deal for Munich biotech start-up Tubulis
Tubulis logo The young biotech company could earn over a billion dollars with the partnership. (Photo: tubules) Frankfurt The Munich-based biotech company Tubulis has agreed a potentially multi-billion dollar deal…
Dax group Bayer is again showing confidence in the growth of its pharmaceutical division
Frankfurt Bayer believes its pharmaceuticals division will grow faster in the long term than previously assumed by many external observers. The Dax group has now almost doubled the sales forecast…
Dax group Bayer is again showing confidence in the growth of its pharmaceutical division
Frankfurt Bayer believes its pharmaceuticals division will grow faster in the long term than previously assumed by many external observers. The Dax group has now almost doubled the sales forecast…
Morphosys: Biotech pioneer in the crisis of confidence
Medical research (icon image) Morphosys share price still fails to recover. (Photo: IMAGO/Westend61) Frankfurt After failures at research partners and disappointing sales figures for its first own drug, the Munich…
Bayer dares big bet on anticoagulant drug Asundexian
Frankfurt The Bayer Group announced one of its largest clinical study programs to date over the weekend. The goal: to develop a successor product for the current bestseller Xarelto. The…
Bayer dares big bet on anticoagulant drug Asundexian
Frankfurt The Bayer Group announced one of its largest clinical study programs to date over the weekend. The goal: to develop a successor product for the current bestseller Xarelto. The…
Michael Burry prepares for Crash
Michael Burry The star investor believes the current upside is a bear market rally and has sold all but one stock. (Photo: Getty Images) Dusseldorf While the mood on Wall…
Michael Burry prepares for Crash
Michael Burry The star investor believes the current upside is a bear market rally and has sold all but one stock. (Photo: Getty Images) Dusseldorf While the mood on Wall…
Michael Burry joins Alphabet and Meta – and bets against Apple
Apple The iPhone maker’s stock fell during the recent stock market sell-off. (Photo: dpa) Dusseldorf For the third time in a row, Michael Burry has completely redesigned his depot. The…
Michael Burry joins Alphabet and Meta – and bets against Apple
Apple The iPhone maker’s stock fell during the recent stock market sell-off. (Photo: dpa) Dusseldorf For the third time in a row, Michael Burry has completely redesigned his depot. The…
Michael Burry joins Alphabet and Meta – and bets against Apple
Apple The iPhone maker’s stock fell during the recent stock market sell-off. (Photo: dpa) Dusseldorf For the third time in a row, Michael Burry has completely redesigned his depot. The…
Evotec seals billion-euro deal with BMS for protein destroyers
Frankfurt With a new deal worth billions, the German biotech company Evotec is expanding its existing alliance with the US pharmaceutical giant Bristol-Myers Squibb (BMS) in the field of “protein…
These are the four new bets from the star investor
cancer cells Star investor Mike Burry has invested in Bristol-Myers Squibb – the market leader in oncology. (Photo: obs/Amgen GmbH) Dusseldorf Star investor Mike Burry has radically restructured his portfolio…
These are the four new bets from the star investor
cancer cells Star investor Mike Burry has invested in Bristol-Myers Squibb – the market leader in oncology. (Photo: obs/Amgen GmbH) Dusseldorf Star investor Mike Burry has radically restructured his portfolio…
These are the four new bets from the star investor
cancer research Star investor Mike Burry has invested in Bristol-Myers Squibb – the market leader in oncology. (Photo: dpa) Dusseldorf Star investor Mike Burry has once again radically restructured his…
In the fight against cancer
Frankfurt The fight against the coronavirus has been in the headlines for two years, but there has also been immense progress in the fight against cancer. Because in the long…
In the fight against cancer
Frankfurt The fight against the coronavirus has been in the headlines for two years, but there has also been immense progress in the fight against cancer. Because in the long…